Reported 21 days ago
Viking Therapeutics has reported promising early trial results for its GLP-1 weight-loss drug, while Morgan Stanley upgraded Roblox to Overweight and set a new price target of $65. Meanwhile, Trump Media & Technology Group is preparing for the upcoming 2024 Election Day following a significant decline in its stock last week.
Source: YAHOO